Octapharma communicates an update on the development of SubQ-8, a novel subcutaneous recombinant FVIII, at ISTH 2019 - Financial Post

Octapharma communicates an update on the development of SubQ-8, a novel subcutaneous recombinant FVIII, at ISTH 2019  Financial Post

LACHEN, Switzerland — Octapharma announced that an update on the clinical development plan and pre-clinical data with SubQ-8 were presented today in a ...